Get the Daily Brief
Latest Biotech News
New Human Genome Studies Resolve Structural Variants and Complex Regions
Two major studies published in Nature detailed enhanced genomic resolution from sequencing 65 diverse human genomes, including full telomere-to-telomere assemblies and comprehensive structural...
Boehringer Ingelheim Awaits FDA Decisions on Lung Cancer and IPF Drugs
Boehringer Ingelheim is poised for major milestones pending FDA regulatory decisions on two late-stage candidates: zongertinib, a HER2-selective tyrosine kinase inhibitor targeting advanced...
Dispatch Bio Launches With $216M to Target Solid Tumors
Dispatch Bio debuted with $216 million in funding, aiming to develop a universal immunotherapy for solid tumors. The biotech, founded in 2022 by CAR-T pioneer Carl June and colleagues, uses a...
Abivax Ulcerative Colitis Drug Posts Strong Phase 3 Data, Shares Surge
Abivax's oral miRNA-124 enhancer, obefazimod, demonstrated significant efficacy in two phase 3 trials for moderately to severely active ulcerative colitis, achieving a 16.4% placebo-adjusted...
Roche Diagnostics Revenues Decline Amid China Pricing Pressures
Roche reported a 3% year-over-year decline in its Diagnostics division revenues for the first half of 2025, attributed in part to healthcare pricing reforms in China. Overall sales rose 4% to CHF...
FDA Extends Review for GSK Multiple Myeloma Drug Blenrep
The U.S. Food and Drug Administration has extended the review period for GSK’s blood cancer drug Blenrep by three months, delaying its potential relaunch in the U.S. The continuation follows a...
Roche Pauses Shipments of Sarepta’s Duchenne Gene Therapy Abroad
Roche has temporarily halted shipments of Elevidys, a Duchenne muscular dystrophy gene therapy marketed outside the United States, amid mounting safety concerns including liver injuries linked to...
Thermo Fisher Beats Q2 Estimates, Raises 2025 Guidance on Cost Cuts
Thermo Fisher Scientific reported better-than-expected Q2 2025 results, with revenues up 3% year-over-year to $10.86 billion and adjusted EPS of $5.36 surpassing consensus. Growth was notable in...
CRISPR-Edited Mosquitoes Halt Malaria Transmission with Single Amino Acid Change
Researchers used CRISPR-Cas9 gene editing to introduce a naturally occurring variant into the mosquito FREP1 gene, rendering mosquitoes resistant to malaria parasite transmission. This single...
New AI System Predicts Muscle Stem Cell Differentiation from Imaging
Researchers developed a nondestructive imaging and machine learning platform that forecasts the efficiency of induced pluripotent stem cells differentiating into muscle stem cells. Using...
AstraZeneca's Gefurulimab Achieves Phase 3 Success in Autoimmune Myasthenia Gravis
AstraZeneca announced positive Phase 3 PREVAIL trial results for gefurulimab, a self-administered C5 complement inhibitor targeting generalized myasthenia gravis (gMG). Gefurulimab met primary and...
AI and Bioinformatics Firms TileDB and Databricks Partner to Integrate Life Sciences Data Platforms
TileDB and Databricks have entered an agreement to integrate their respective data management platforms for healthcare and life sciences. This collaboration will enable data from TileDB’s...
Dispatch Bio Launches with $216M to Target Solid Tumors
Dispatch Bio emerged with $216 million in funding, unveiling a novel immunotherapy platform designed to treat diverse and hard-to-target solid tumors. Founded in 2022 through collaborations...
FDA Delays and Challenges in Gene and Cancer Therapy Approvals
Recent regulatory setbacks have impacted several biotech therapies. The FDA extended the review for GSK’s multiple myeloma drug Blenrep as the company prepares a relaunch after its previous...
Abivax Ulcerative Colitis Drug Scores Strong Phase 3 Results
Abivax’s investigational oral miRNA-enhancer drug obefazimod demonstrated compelling clinical remission in two Phase 3 trials involving moderately to severely active ulcerative colitis patients...
Sanofi Acquires Vicebio to Expand Respiratory Vaccine Portfolio
Sanofi announced a $1.15 billion upfront acquisition of London-based biotech Vicebio, enhancing its position in respiratory virus vaccines. Vicebio’s Molecular Clamp technology stabilizes viral...
Thermo Fisher Scientific Raises 2025 Guidance Following Robust Q2
Thermo Fisher Scientific reported a 3 percent year-over-year revenue growth to $10.86 billion in Q2, beating analyst expectations. The company raised its full-year revenue guidance to between...
Long-Read Sequencing Sheds Light on Human Genome Structural Variation
Two independent international research groups applied long-read DNA sequencing to samples from the 1000 Genomes Project, unveiling an unprecedented view of structural genetic variation across...
Gut Microbial Protein Rapidly Signals Appetite Suppression to Brain
Research from Duke University elucidated a gut-brain communication path enabling real-time appetite regulation through detection of a microbial protein. Specialized colonic neuropod cells sense...
Advances in Machine Learning and Automation for Biotech Discovery and Manufacturing
Recent technological innovations harnessing machine learning and automation are transforming biotech research and production. Techniques such as Bayesian optimization integrated with...